Is institutional weakness the main barrier to innovation in the generic pharmaceutical industries in fast-growing low developed countries?: A case study

Mamun Ala

Is institutional weakness the main barrier to innovation in the generic pharmaceutical industries in fast-growing low developed countries? A case study

Human Resource Management and Strategic Management

Research output: Contribution to conference › Conference paper › peer-review

Original language	English
Publication status	Published - 19 Feb 2020
Event	Australia and New Zealand International Business Academy (ANZIBA) Conference - Dr. Chau Wak Wing Building, UTS Business School Building, Ultimo, Sydney, Australia Duration: 17 Feb 2020 → 19 Feb 2020 https://www.anziba.org/wp-content/uploads/2020/02/ANZIBA-2020-Program.pdf (Conference programme)

Conference

Conference	Australia and New Zealand International Business Academy (ANZIBA) Conference
Abbreviated title	ANZIBA 2020
Country/Territory	Australia
City	Sydney
Period	17/02/20 → 19/02/20
Internet address	https://www.anziba.org/wp-content/uploads/2020/02/ANZIBA-2020-Program.pdf (Conference programme)

Cite this

@conference{dcc7cbb41ae54f0b8e0dc7a11ba08c47,

title = "Is institutional weakness the main barrier to innovation in the generic pharmaceutical industries in fast-growing low developed countries?: A case study",

author = "Mamun Ala",

year = "2020",

month = feb,

day = "19",

language = "English",

note = "Australia and New Zealand International Business Academy (ANZIBA) Conference, ANZIBA 2020 ; Conference date: 17-02-2020 Through 19-02-2020",

url = "https://www.anziba.org/wp-content/uploads/2020/02/ANZIBA-2020-Program.pdf",

}

Is institutional weakness the main barrier to innovation in the generic pharmaceutical industries in fast-growing low developed countries? A case study. / Ala, Mamun.
2020. Paper presented at Australia and New Zealand International Business Academy (ANZIBA) Conference, Sydney, New South Wales, Australia.

Research output: Contribution to conference › Conference paper › peer-review